RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia
Clinical trial NCT06797531 · RECRUITING
Trial details
- NCT number
- NCT06797531
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-27
- Primary completion
- 2028-11-30
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.